Qiagen to buy Abbott SARS (severe acute respiratory syndrome) test partner artus
This article was originally published in Clinica
Executive Summary
Qiagen, of Venlo, the Netherlands, has agreed to pay $39.2m in cash to acquire artus, a German firm that makes diagnostic tests based on DNA analysis. artus hit the headlines in 2003 when it won the race to launch a commercial test for the coronavirus that causes severe acute respiratory syndrome (SARS), using PCR technology licensed from Roche.